In this paper, the application of a technique to evaluate in vivo biodistribution of magnetic nanoparticles (MNP) is addressed: the Multichannel AC Biosusceptometry System (MC-ACB). It allows real-time assessment of magnetic nanoparticles in both bloodstream clearance and liver accumulation, where a complex network of inter-related cells is responsible for MNP uptake. Based on the acquired MC-ACB images, we propose a mathematical model to help understand the distribution and accumulation pharmacokinetics of MNP. MC-ACB showed a high time resolution to detect and monitor MNP, providing sequential images over the particle biodistribution. Utilizing the MC-ACB instrument, we assessed regions corresponding to the heart and liver, and we determined the MNP transfer rates between the bloodstream and the liver. The pharmacokinetic model resulted in having a strong correlation with the experimental data, suggesting that the MC-ACB is a valuable and accessible imaging device to assess in vivo and real-time pharmacokinetic features of MNP.
28 January 2020 in Bulletin of Mathematical Biology
Dosage and frequency of treatment schedulesare important for successful chemotherapy.However, in this work we argue that cell-kill response and tumoralgrowth should not be seen as separate and therefore are essential in a mathematical cancer model.This paper presents a mathematical model for sequencing of cancer chemotherapy andsurgery. Our purpose is to investigate treatments for large human tumoursconsidering a suitable cell-kill dynamics. Weuse some biological and pharmacological data in a numerical approach,where drug administration occurs in cycles (periodic infusion)and surgery is performed instantaneously. Moreover, we alsopresent an analysis of stabilityfor a chemotherapeutic model with continuous drug administration.According to Norton & Simon [22], our results indicate that chemotherapy is lessefficient in treating tumours that have reached a plateau level of growingand that a combination with surgical treatment can provide better outcomes.